Olema Pharmaceuticals Inc.

12/02/2024 | Press release | Distributed by Public on 12/02/2024 06:00

Olema Oncology Announces New Clinical Trial Collaboration and Supply Agreement with Novartis in Frontline Metastatic Breast Cancer as well as $250 Million Equity Private Placement

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.